5th Annual Indiana Allergy and Immunology Society Meeting
7:00AM - 2:55PM on Saturday, September 30, 2023
7:00 AM – 8:00 AM Breakfast/Registration/Networking
8:00 AM – 9:00 AM
9:00 AM – 10:00 AM
10:00 AM – 10:30 AM Coffee Break/Exhibit Hall
10:30 AM – 11:30 AM Allergy & Immunology Fellow Presentations
10:30 AM – 11:00 AM
11:00 AM – 11:30 AM
11:30 AM – 12:45 PM Lunch & Annual Business Meeting/Exhibit Hall/Networking
12:45 PM – 1:45 PM
1:45 PM – 2:45 PM
2:45 PM – 2:55 PM Closing Remarks and Adjourn
This activity is jointly provided by the American College of Allergy, Asthma and Immunology and Indiana Allergy and Immunology Society.
Target Audience
Practicing allergists, primary care physicians and allied healthcare professionals.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology and The Indiana Allergy and Immunology Society. The American College of Allergy, Asthma & Immunology is accredited by the ACCME to provide continuing medical education for physicians.
Learning Objectives
At the end of this activity, participants should be able to:
Organize a treatment plan for a patient with drug hypersensitivity.
Collect data on how to become involved in local, state and national associations and organize ways to make changes for our patients and our profession.
Summarize differences in treating pediatric and adult drug hypersensitivity.
Construct a plan for patients with PID, understanding the need to refer, when appropriate.
Critique fellows’ case presentations of unique cases at Indiana University
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.